Gemini Therapeutics (GMTX) Stock Chart & Stock Price History $53.38 -1.37 (-2.50%) As of 07/7/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrendsBuy This Stock Gemini Therapeutics Stock Price Performance The Gemini Therapeutics (GMTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 14.50%, with a year-to-date return of -13.34%. In the past month, the stock has increased 11.19%, reflecting recent market activity. As of the latest close, Gemini Therapeutics traded at $54.75 with a market cap of $2.37 billion and volume of 218,300 shares. Receive GMTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.39%1 Month Performance+11.19%3 Month Performance+36.17%Year-To-Date Performance-13.34%1 Year Performance+14.50% GMTX Stock Chart for Tuesday, July, 8, 2025 GMTX Chart by TradingView Gemini Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/08/2025$54.75$53.38-2.50%$54.60$52.70195,341 shs$2.31 billion07/07/2025$54.75$54.75$55.26$53.17218,300 shs$2.37 billion07/04/2025$53.17$54.75+2.97%$55.26$53.17218,300 shs$2.37 billion07/03/2025$51.13$53.17+3.99%$53.66$51.03503,663 shs$2.30 billion07/02/2025$52.96$51.13-3.46%$53.65$51.01285,856 shs$2.22 billion07/01/2025$54.50$52.96-2.83%$55.45$52.52313,031 shs$2.29 billion06/30/2025$54.50$54.50$55.52$53.381.06 million shs$2.36 billion06/27/2025$53.92$54.13+0.40%$54.36$52.80220,107 shs$2.35 billion06/26/2025$55.00$53.92-1.97%$54.75$52.10326,647 shs$2.34 billion06/25/2025$51.68$55.00+6.42%$55.02$50.84561,392 shs$2.38 billion Get the Latest News and Ratings for GMTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/24/2025$51.61$51.68+0.14%$51.81$49.73288,372 shs$2.24 billion06/23/2025$51.61$51.61$51.84$49.85413,983 shs$2.24 billion06/20/2025$50.09$50.09$51.15$48.87321,187 shs$2.17 billion06/19/2025$50.05$50.09+0.08%$51.15$48.87321,187 shs$2.17 billion06/18/2025$52.02$50.05-3.79%$51.79$50.03407,716 shs$2.17 billion06/17/2025$53.71$52.02-3.15%$53.85$51.37415,134 shs$2.25 billion06/16/2025$53.71$53.71$54.13$51.52705,221 shs$2.33 billion06/13/2025$50.86$52.71+3.64%$53.30$49.80396,554 shs$2.28 billion06/12/2025$53.07$50.86-4.16%$53.52$50.85397,276 shs$2.20 billion06/11/2025$51.42$53.07+3.21%$54.28$51.36359,190 shs$2.30 billion06/10/2025$50.02$51.42+2.80%$51.53$49.27639,815 shs$2.23 billion06/09/2025$50.02$50.02$50.15$48.50223,217 shs$2.17 billion Related Companies BridgeBio Pharma Stock Price Chart Blueprint Medicines Stock Price Chart Verona Pharma PLC American Depositary Share Stock Price Chart Roivant Sciences Stock Price Chart Elanco Animal Health Stock Price Chart Revolution Medicines Stock Price Chart Legend Biotech Stock Price Chart Grifols Stock Price Chart TG Therapeutics Stock Price Chart Nuvalent Stock Price Chart Receive GMTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GMTX) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored$3,200 from your phone?No charts. No crypto. No stock picking. With just a regular brokerage app and Jeff Clark’s “Crossfire” meth...TradeSmith | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gemini Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gemini Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GMTX Stock Alerts